Results from a new JAMA Network study support the large-scale use of FIT tests. The findings show that those who complete one or more fecal immunochemical test (FIT) screenings are associated with a ...

A national survey finds patients want personal contact after positive cancer results, with psychosocial fears outweighing cost and transportation concerns. Pharmacy-based colorectal cancer (CRC) ...

Colonoscopy conducted beyond 3 months and up to 24 months after a positive fecal immunochemical test are not linked to an ...

Close to 50,000 Americans will die from colorectal cancer (CRC) in 2016, making it the second-leading cause of cancer-related death in this country (behind only lung cancer).1 What makes the statistic ...

Sensitivity varied from 10.1 to 36.7%, and specificity varied from 85.5 to 96.6% for advanced colorectal neoplasia. HealthDay News — Fecal immunochemical tests (FITs) have variable sensitivity and ...

SAN DIEGO — In the ever-expanding options for colorectal cancer (CRC) screening, blood tests using precision medicine are becoming more advanced and convenient than ever; however, caveats abound, and ...

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

Adding a deadline to a mailed invitation for FIT colorectal cancer screening resulted in improved return rates. The highest return rate was seen with a 2-week deadline. This intervention can be easily ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Younger vs. older patients achieved a higher rate of ...

Eleven years ago, my life was forever changed when I lost my beloved husband, Len Atkins, to colorectal cancer. He was only 48, a time when most people wouldn't even consider a colonoscopy. It's a ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...